3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
cyclopia sequence
14
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Multiple Myeloma
3
Breast Neoplasms
3
Pain
2
Neoplasms, Plasma Cell
2
Head and Neck Neoplasms
2
Wilms Tumor
1
Waldenstrom Macroglobulinemia
1
Thromboembolism
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Spinal Cord Neoplasms
1
Sleepiness
1
Sezary Syndrome
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Cognitive Complications
1
Peripheral Nervous System Diseases
1
Peptic Ulcer
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Parasomnias
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Interventions
Propofol
4
Saline Solution
3
Dexmedetomidine
3
remimazolam
2
Sugammadex
1
Sufentanil
1
Sodium Chloride
1
Ropivacaine
1
Pyridostigmine Bromide
1
Neuroleptanalgesia
1
Nalbuphine
1
Minocycline
1
Midazolam
1
Methylene Blue
1
Ketamine
1
Injections
1
Ibuprofen
1
Duloxetine Hydrochloride
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Emergence Delirium
×
Minocycline
×
Clear all
NCT02928692
2020-01-28
MAPOCD
RenJi Hospital
Phase 3
Unknown
750 enrolled